Fractional
Leadership
Deep Domain
Expertise
De-risk Commercialization
Clarity AI HITL Commercial Workflow
Experienced Leadership
Team
Launch and Scale
Clinical Validation to Market Adoption
You built the breakthrough
We operationalize adoption
Precision. Pace. Results.
​
-
Unblock procurement
-
Align reimbursement
-
Drive physician uptake
The Window of Opportunity is Tight
Market Leaders are determined early
Strong positioning + adoption in the first 18–24 months sets the winners.
​
Your window is short
Early momentum is the key to lasting success.
We Know This Landscape
Clinical success is just the start
Market traction drives leadership
That’s what we deliver
Commercialization Challenge
​1. Procurement Hurdles
-
Lengthy, multi-step purchasing cycles (3–5 contract layers typical)
-
“New tech” clauses often trigger pilot program requirements
-
Hospital committees delay adoption pending procedure training and approval
-
Requires CPT/HCPCS code clarity and confirmed reimbursement pathway
-
Institutional inertia slows vendor onboarding, especially for novel devices
​​
2. Stiff Competition
-
Incumbents use bundled pricing and service agreements to block entry
-
Existing players already have reimbursement, trust, and clinical champions
-
Buyers hesitant to switch due to entrenched vendor relationships
-
Clinical results alone are not enough to displace trusted legacy tech
3. Cautious Physicians
-
Only a small % of early adopters willing to trial new procedures
-
General physician base shows optimism without commitment
-
Clinical integration slows due to training needs and procedural habit change
-
Surgeons want long-term data, workflow fit, and peer endorsement
4. Demanding Payers
-
Require budget impact models and HEOR data—not just trial outcomes
-
Cost-effectiveness vs. current standard-of-care must be demonstrated
-
U.S.: Mix of private payers, Medicare, Medicaid — each with unique barriers
-
Canada: Provincial public coverage demands health economics proof for listing
5. Board & Investor Pressure
-
Board expects early traction and revenue visibility
-
Pressure to hit commercial KPIs despite systemic adoption delays
-
Investor confidence tied to pacing toward market capture milestones
-
Must balance clinical progress with go-to-market execution​
​
How We Help
1. Accelerate Procurement
-
Pre-negotiate pilots with IDNs and leading hospitals
-
Build a New Tech Toolkit: workflow, budget, training, early outcomes
-
Engage VACs with ROI models tailored to site type
-
Navigate GPOs and contracts through expert-led access support
2. Outmaneuver Incumbents
-
Unbundle legacy contracts and reveal hidden costs
-
Offer value-based or performance-linked pricing
-
Activate clinical champions with side-by-side performance data
-
Target regions where competitor engagement is weak
​​
3. Drive Physician Adoption
-
Launch KOL-led onboarding, mentorship, and live case programs
-
Focus on early adopter EPs ready to lead procedural shifts
-
Highlight workflow fit, safety profile, and patient outcomes
-
Flatten learning curve with simulation and peer case access
4. Align Early with Payers
-
Submit HEOR models and budget impact dossiers
-
Apply for NTAP and new-tech reimbursement pathways
-
Form a payer advisory board with former medical directors
-
Ensure your economic story is stronger than your clinical one
5. Deliver on Board & Investor Expectations
-
Phase-gate traction metrics: pilot > contract > revenue milestones
-
Build KPI dashboards across payer, provider, and procurement traction
-
Quantify TAM, conversion roadmap, and cash flow inflection points
-
Pursue co-distribution to accelerate time-to-scale
​​
* Execution Catalysts
-
Lead with lighthouse centers of excellence
-
Equip your field team with battlecards, ROI tools, and objection handling
-
Use HRS and other EP conferences to create conversion momentum
-
Deploy video case studies that drive clinical confidence and economic proof
Why Strategic Growth AI
Unique Advantages
​
Commercialization experts
-
AI-powered cardiac medtech commercialization platform
-
KPI engagement
-
Canadian ecosystem advantages for global market expansion
Investment & Timeline (TBD)
-
Rapid deployment program
-
Force Multiplier
-
Engage with team
-
Cost effective
​
Transform to Market Leadership
Ready to Transform Clinical Excellence Into Market Leadership?
Contact Strategic Growth AI to learn how we accelerate cardiac medtech commercialization across Canada, US, and European markets through AI-powered intelligence, validated economic evidence, and risk-mitigated execution.
The $11.2B opportunity won't wait. Neither should you.
​
Strategic Growth AI provides decision-support services and does not guarantee specific outcomes. Market projections based on published research and current industry modeling standards; actual results may vary materially.